Delaying Coverage of Weight-loss Meds Won’t Cure Obesity

Delaying Coverage of Weight-loss Meds Won’t Cure Obesity

In an interview this month, Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., appeared open to the idea of Medicare covering drugs like Ozempic and Wegovy for beneficiaries with obesity.

“Ideally, over the long term, we’d like to see . . . those drugs available for people after they try other interventions,” he said.

Delaying coverage of these breakthrough weight-loss medications is not the right approach.

Read the entire op-ed here.